A Clinical Trial to Assess the Safety and Immunogenicity of Nanocovax in Heathy Volunteers
Clinical trial NCT04683484 · UNKNOWN
Trial details
- NCT number
- NCT04683484
- Sponsor
- Nanogen Pharmaceutical Biotechnology Joint Stock Company
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-10
- Primary completion
- 2021-06-10
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.